MenQuadfi meningococcal
Selected indexed studies
- MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY. (Ann Pharmacother, 2022) [PMID:34459258]
- A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT). (Hum Vaccin Immunother, 2025) [PMID:40493501]
- MenQuadfi - a new meningococcal (A, C, W, and Y) vaccine. (Med Lett Drugs Ther, 2021) [PMID:33976094]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT). (2025) pubmed
- Adult immunization. (2022) pubmed
- MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY. (2022) pubmed
- MenQuadfi - a new meningococcal (A, C, W, and Y) vaccine. (2021) pubmed
- Meningococcal Vaccines. (2006) pubmed
- [Vaccination prophylaxis for recurrent invasive meningococcal diseases]. (2022) pubmed
- Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®. (2022) pubmed
- Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial. (2025) pubmed
- Analytical Challenges in Novel Pentavalent Meningococcal Conjugate Vaccine (A, C, Y, W, X). (2024) pubmed
- Penbraya: A pentavalent meningococcal vaccine. (2024) pubmed